Overview
Olaplex Holdings Inc Q2 net sales rise 2.3% to $106.3 mln, beating estimates
Company reports Q2 net loss of $7.7 mln, down from $5.8 mln profit
Adjusted EBITDA for Q2 beats expectations, reaching $24.55 mln
Outlook
Olaplex expects high single-digit sales decline in Q3 2025
Olaplex anticipates high single-digit sales increase in Q4 2025
Company reiterates FY 2025 net sales guidance of $410 mln to $431 mln
Olaplex sees FY 2025 adjusted EBITDA margin between 20% and 22%
Result Drivers
PROFESSIONAL CHANNEL - Sales in the Professional channel rose 12.1% to $37.4 mln, contributing to overall revenue growth
DIRECT-TO-CONSUMER - Direct-To-Consumer sales increased 12.8% to $38.5 mln, supporting overall sales performance
SPECIALTY RETAIL DECLINE - Specialty Retail sales fell 16.7% to $30.4 mln, impacting total sales growth
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Sales
Beat
$106.28 mln
$100.30 mln (6 Analysts)
Q2 EPS
-$0.01
Q2 Adjusted EBITDA
Beat
$24.55 mln
$20.90 mln (7 Analysts)
Q2 Adjusted EBITDA Margin
23.1%
Q2 Gross Profit
$75.64 mln
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy", 8 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the personal products peer group is "buy."
Wall Street's median 12-month price target for Olaplex Holdings Inc is $1.75, about 19.4% above its August 6 closing price of $1.41
The stock recently traded at 19 times the next 12-month earnings vs. a P/E of 19 three months ago
Press Release: ID:nGNX4N6qt3
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)